LabGenomics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for LabGenomics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 82.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
There's No Escaping LabGenomics Co., Ltd.'s (KOSDAQ:084650) Muted Revenues Despite A 46% Share Price Rise
Jan 06
Not Many Are Piling Into LabGenomics Co., Ltd. (KOSDAQ:084650) Stock Yet As It Plummets 26%
Nov 17Is LabGenomics (KOSDAQ:084650) Weighed On By Its Debt Load?
Nov 08Slammed 29% LabGenomics Co., Ltd. (KOSDAQ:084650) Screens Well Here But There Might Be A Catch
Sep 21Market Might Still Lack Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650) Even After 35% Share Price Boost
Aug 06Is LabGenomics (KOSDAQ:084650) Using Too Much Debt?
Jul 27Market Still Lacking Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650)
Apr 09If You Like EPS Growth Then Check Out LabGenomics (KOSDAQ:084650) Before It's Too Late
Mar 31In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LabGenomics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 85,817 | -22,336 | -9,370 | -4,166 | N/A |
| 6/30/2024 | 85,341 | -21,175 | -13,787 | -9,844 | N/A |
| 3/31/2024 | 78,360 | -18,038 | -12,632 | -9,885 | N/A |
| 12/31/2023 | 73,127 | -4,674 | -9,023 | -3,827 | N/A |
| 9/30/2023 | 69,848 | 4,135 | 23,559 | 29,176 | N/A |
| 6/30/2023 | 73,188 | 13,558 | 25,775 | 31,806 | N/A |
| 3/31/2023 | 79,804 | 14,483 | 64,335 | 72,528 | N/A |
| 12/31/2022 | 144,773 | 48,397 | 30,625 | 68,955 | N/A |
| 9/30/2022 | 187,009 | 74,151 | 29,586 | 67,149 | N/A |
| 6/30/2022 | 215,952 | 90,800 | 49,761 | 87,031 | N/A |
| 3/31/2022 | 248,011 | 108,702 | 11,726 | 58,373 | N/A |
| 12/31/2021 | 202,407 | 83,855 | 51,547 | 65,362 | N/A |
| 9/30/2021 | 173,039 | 64,682 | 35,933 | 49,661 | N/A |
| 6/30/2021 | 146,336 | 49,148 | 28,518 | 42,302 | N/A |
| 3/31/2021 | 141,632 | 53,802 | 44,841 | 47,244 | N/A |
| 12/31/2020 | 119,478 | 42,766 | 44,857 | 46,372 | N/A |
| 9/30/2020 | 97,279 | 38,382 | 25,100 | 26,614 | N/A |
| 6/30/2020 | 78,956 | 29,479 | 18,521 | 20,125 | N/A |
| 3/31/2020 | 38,237 | 3,175 | 5,891 | 5,441 | N/A |
| 12/31/2019 | 33,175 | 962 | 1,267 | 3,188 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A084650's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A084650's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A084650's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A084650's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A084650's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A084650's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/06 00:44 |
| End of Day Share Price | 2025/01/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LabGenomics Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyung Soo Kim | Hanwha Investment & Securities Co., Ltd. |
| Wan Ku | iM Securities |
| Seung Kyu Jung | Kiwoom Securities Co., Ltd. |